EVAg

African swine fever virus p30 monoclonal antibody IgG2a (1F11.D4.A12)

African swine fever virus p72 monoclonal antibody IgG2b (4G6.G3.G7)

Aujeszky's Disease virus glycoprotein E (gE) antiserum (Rabbit 20C)

Classical swine fever virus (CSFV) E2 glycoprotein (gp55) antiserum (Rabbit #25H)

Cygnet River virus HA protein antiserum (Rabbit #606)

Eubenangee virus VP7 antiserum (Rabbit #798)

Hendra virus N protein antiserum (Rabbit #369)

Hendra virus G protein antiserum (Rabbit #615)

Avian influenza A virus NP antiserum (Rabbit #690)

Kunjin virus NS1 antiserum (Rabbit #17)

Lumpy skin disease virus LSDV074 (p32) protein antiserum (Rabbit #27J)

Lumpy skin disease virus p32 monoclonal antibody IgG2a (25F3.A3.D9)

Nelson Bay virus mu (μ) protein antiserum (Rabbit #672)

Nelson Bay virus sigma (σ) protein antiserum (Rabbit #658)

Nelson Bay virus lambda (λ) protein antiserum (Rabbit #661)

Nipah virus G protein antiserum (Rabbit #612)

Nipah virus N protein antiserum (Rabbit #366)

Pan-orbivirus NS2 antiserum (Rabbit #17)

Human Immunodeficiency Virus (HIV) drug resistance remains a significant health issue that challenges treatment and prevention. The objective of this 3-week course is to learn bioinformatics techniques for the analysis of next-generation HIV sequencing results. This covers both HIV-1 and HIV-2. Teaching objectives include data curation, alignment, phylogenetics for typing, identification of drug resistance mutations, production of a resistance score, and interpretation. This course does not include genotyping itself, only sequence analysis and interpretation, as described above.

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 24x4 rxns) for real time RT-PCR of tick borne encephalitis virus (Taqman) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only).

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 24x4 rxns) for real time RT-PCR of Usutu virus (Taqman) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only).

Lyophilized encapsidated RNA for SARS-CoV-2 real time RT-PCR targeting region of the N(CUB) gene (for 100 Rxns) AND Lyophilized ready-to-use primers and probe (Lyoph-P&P) for real time RT-PCR (96 rxns in the form of 4x24 rnxs). Target, primers and probe designed by Charité (CUB) Berlin. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase

Lyophilized encapsidated RNA for SARS-CoV-2 real time RT-PCR targeting region of the RdRp (IP2/IP4) gene (for 100 Rxns) AND Lyophilized ready-to-use primers and probe (Lyoph-P&P) for real time RT-PCR (96 rxns in the form of 4x24 rnxs). Target, primers and probe designed by Institut Pasteur Paris. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase

Lyophilized encapsidated RNA for SARS-CoV-2 real time RT-PCR targeting region of the RdRp (Wuhan/CUB) gene (for 100 Rxns in the form of 4x 25 rnxs) AND Lyophilized ready-to-use primers and probe (Lyoph-P&P) for real time RT-PCR (96 rxns in the form of 12x8 rnxs). Target, primers and probe designed by CUB Berlin. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase

Lyophilized encapsidated RNA for SARS-CoV-2 real time RT-PCR targeting region of the RdRp (Wuhan/CUB) gene (for 25 Rxns) AND Lyophilized ready-to-use primers and probe (Lyoph-P&P) for real time RT-PCR (24 rxns in the form of 3x8 rnxs). Target, primers and probe designed by CUB Berlin. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase